| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fd543243bd4ab5d0e5a57d3f64026bb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B1-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B1-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-587 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-48 |
| filingDate |
2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e350627adafec5984a3a4224f407d2 |
| publicationDate |
2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016008437-A1 |
| titleOfInvention |
Glyceryl 1-palmitate-2-linoleate-3-oleate compound, formulation, and preparation method and application thereof |
| abstract |
The present invention relates to a compound having the structure (I): glyceryl 1-palmitate-2-linoleate-3-oleate; the present invention also comprises the method of obtaining the compound of the present invention by the preparation of coix seed oil from a raw material of coix seed powder, the preliminary isolation of glyceryl 1-palmitate-2-linoleate-3-oleate, and the secondary isolation of same. The present invention also relates to a pharmaceutical formulation containing said compound having structure (I), the preparation method thereof, and the application of said compound and said formulation as an anti-tumour medicine. |
| priorityDate |
2014-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |